ERNUWA
Allergan Pharmaceuticals International Limited
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87325233 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Law Office Assigned | L10 |
| Employee Name | WEIGLE, KATHERINE CONN |
Timeline
| 2017-02-06 | Application Filed |
| 2017-10-24 | Published for Opposition |
| 2017-12-19 | Location: INTENT TO USE SECTION |
| 2019-01-21 | Abandon |
| 2019-01-21 | Status: Dead/Abandoned |
| 2019-01-22 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Allergan Pharmaceuticals International Limited |
| Entity Statement | private company limited by shares (prp. ltd.) |
| Address | Clonshaugh Industrial Estate Coolock, Dublin 17 IE |
| Legal Entity Type | |
| Legal Entity State | IE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Oral, transdermal, injectable and intravaginal contraceptive preparations; hormone replacement therapy preparations |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-02-09 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-02-09 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-03-13 | 3 DOCK D:Assigned to Examiner |
| SUSPENSION LETTER WRITTEN | 2017-03-13 | 4 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2017-03-13 | 5 GNSL F:First Action |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2017-03-13 | 6 GNS3 O:Outgoing Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-09-13 | 7 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-10-04 | 8 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2017-10-24 | 9 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-10-24 | 10 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2017-12-19 | 11 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2018-05-07 | 12 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2018-05-07 | 13 EXT1 S: |
| EXTENSION 1 GRANTED | 2018-05-07 | 14 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-05-09 | 15 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2019-01-21 | 16 ABN6 S: |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2019-01-22 | 17 MAB6 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ERNUWA 88271735 not registered Live/Pending |
Allergan Sales, LLC 2019-01-22 |
 ERNUWA 87325233 not registered Dead/Abandoned |
Allergan Pharmaceuticals International Limited 2017-02-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 